234 related articles for article (PubMed ID: 18663657)
1. Complexation study of the anticancer agent EO-9 with 2-hydroxypropyl-beta-cyclodextrin.
Beijnen JH; van der Schoot SC; Nuijen B; Flesch FM; Gore A; Mirejovsky D; Lenaz L
Drug Dev Ind Pharm; 2008 Oct; 34(10):1130-9. PubMed ID: 18663657
[TBL] [Abstract][Full Text] [Related]
2. Influence of levodropropizine and hydroxypropyl-β-cyclodextrin association on the physicochemical characteristics of levodropropizine loaded in hydroxypropyl-β-cyclodextrin microcontainers: Formulation and in vitro characterization.
Yousaf AM; Qadeer A; Raza SA; Chohan TA; Shahzad Y; Din FU; Khan IU; Hussain T; Alvi MN; Mahmood T
Polim Med; 2019; 49(1):35-43. PubMed ID: 31769938
[TBL] [Abstract][Full Text] [Related]
3. Alpinetin/hydroxypropyl-β-cyclodextrin host-guest system: preparation, characterization, inclusion mode, solubilization and stability.
Ma SX; Chen W; Yang XD; Zhang N; Wang SJ; Liu L; Yang LJ
J Pharm Biomed Anal; 2012; 67-68():193-200. PubMed ID: 22633603
[TBL] [Abstract][Full Text] [Related]
4. Dihydroartemisinin-cyclodextrin complexation: solubility and stability.
Ansari MT; Iqbal I; Sunderland VB
Arch Pharm Res; 2009 Jan; 32(1):155-65. PubMed ID: 19183889
[TBL] [Abstract][Full Text] [Related]
5. Development of a bladder instillation of the indoloquinone anticancer agent EO-9 using tert-butyl alcohol as lyophilization vehicle.
van der Schoot SC; Nuijen B; Flesch FM; Gore A; Mirejovsky D; Lenaz L; Beijnen JH
AAPS PharmSciTech; 2007 Aug; 8(3):E61. PubMed ID: 17915811
[TBL] [Abstract][Full Text] [Related]
6. Purity profile of the indoloquinone anticancer agent EO-9 and chemical stability of EO-9 freeze dried with 2-hydroxypropyl-beta-cyclodextrin.
van der Schoot SC; Vainchtein LD; Nuijen B; Gore A; Mirejovsky D; Lenaz L; Beijnen JH
Pharmazie; 2008 Nov; 63(11):796-805. PubMed ID: 19069239
[TBL] [Abstract][Full Text] [Related]
7. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
Srivalli KM; Mishra B
AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
[TBL] [Abstract][Full Text] [Related]
8. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.
Pralhad T; Rajendrakumar K
J Pharm Biomed Anal; 2004 Feb; 34(2):333-9. PubMed ID: 15013147
[TBL] [Abstract][Full Text] [Related]
9. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
[TBL] [Abstract][Full Text] [Related]
10. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
Jug M; Bećirević-Laćan M
Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497
[TBL] [Abstract][Full Text] [Related]
11. Characterization of an inclusion complex of cholesterol and hydroxypropyl-beta-cyclodextrin.
Williams RO; Mahaguna V; Sriwongjanya M
Eur J Pharm Biopharm; 1998 Nov; 46(3):355-60. PubMed ID: 9885309
[TBL] [Abstract][Full Text] [Related]
12. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
[TBL] [Abstract][Full Text] [Related]
13. Improvement of gliquidone hypoglycaemic effect in rats by cyclodextrin formulations.
Miro A; Quaglia F; Sorrentino U; La Rotonda MI; D'Emmanuele Di Villa Bianca R; Sorrentino R
Eur J Pharm Sci; 2004 Sep; 23(1):57-64. PubMed ID: 15324923
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of ibuproxam complexation with amorphous beta-cyclodextrin derivatives in solution and in the solid state.
Mura P; Zerrouk N; Faucci M; Maestrelli F; Chemtob C
Eur J Pharm Biopharm; 2002 Sep; 54(2):181-91. PubMed ID: 12191690
[TBL] [Abstract][Full Text] [Related]
15. Preparation and comparison of binary and ternary inclusion complexes of aripiprazole using L-arginine/lysine and MβCD/HPβCD by using different molar ratios.
Awais S; Afridi M; Batool A; Ansari MT; Sultana K; Momal H; Alsanie WF; S Alamri A; Alhomrani M
Pak J Pharm Sci; 2024 Jan; 37(1(Special)):245-255. PubMed ID: 38747276
[TBL] [Abstract][Full Text] [Related]
16. Complexation of the interferon inducer, bropirimine, with hydroxypropyl-beta-cyclodextrin.
Echezarreta-López M; Torres-Labandeira JJ; Castiñeiras-Seijo L; Santana-Penín L; Vila-Jato JL
Eur J Pharm Sci; 2000 Feb; 9(4):381-6. PubMed ID: 10664478
[TBL] [Abstract][Full Text] [Related]
17. Sulfamethoxazole:hydroxypropyl-β-cyclodextrin complex: preparation and characterization.
Garnero C; Aiassa V; Longhi M
J Pharm Biomed Anal; 2012 Apr; 63():74-9. PubMed ID: 22361661
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound-mediated molecular self-assemble of thymol with 2-hydroxypropyl-β-cyclodextrin for fruit preservation.
Sun C; Cao J; Wang Y; Chen J; Huang L; Zhang H; Wu J; Sun C
Food Chem; 2021 Nov; 363():130327. PubMed ID: 34144424
[TBL] [Abstract][Full Text] [Related]
19. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin.
Mura P; Faucci MT; Bettinetti GP
Eur J Pharm Sci; 2001 May; 13(2):187-94. PubMed ID: 11297903
[TBL] [Abstract][Full Text] [Related]
20. Investigation of inclusion complex of epothilone A with cyclodextrins.
Xiao CF; Li K; Huang R; He GJ; Zhang JQ; Zhu L; Yang QY; Jiang KM; Jin Y; Lin J
Carbohydr Polym; 2014 Feb; 102():297-305. PubMed ID: 24507285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
